Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.62 EUR | +1.89% | +5.12% | -1.71% |
Apr. 30 | Emak best performer; Bialetti trailing. | AN |
Apr. 02 | Fine Foods narrows loss in 2023; up 22 percent in revenue | AN |
Summary
- From a short-term investment perspective, the company presents a deteriorated fundamental configuration.
- The company has a good ESG score relative to its sector, according to Refinitiv.
Strengths
- The earnings growth currently anticipated by analysts for the coming years is particularly strong.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
- Over the past four months, analysts' average price target has been revised upwards significantly.
- Analyst opinion has improved significantly over the past four months.
- The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.
- Historically, the company has been releasing figures that are above expectations.
Weaknesses
- The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Food Processing
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-1.71% | 222M | A- | ||
+13.21% | 8.01B | D+ | ||
-0.47% | 7.36B | C- | ||
+12.30% | 6.54B | - | ||
-6.99% | 3.73B | D | ||
-7.95% | 3.42B | B- | ||
-4.78% | 1.24B | - | - | |
+12.61% | 935M | - | ||
-43.32% | 886M | B+ | ||
-22.54% | 827M | C+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- FF Stock
- Ratings Fine Foods & Pharmaceuticals N.T.M. S.p.A.